Related Experiment Videos
Seizures and metabolic disease
Phillip L Pearl1, Heather D Bennett, Zarir Khademian
1Department of Neurology, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010, USA. ppearl@cnmc.org
Current Neurology and Neuroscience Reports
|March 4, 2005
Summary
Myoclonic seizures and early onset in infants can indicate inborn errors of metabolism. Early diagnosis and treatment are crucial for managing these rare metabolic disorders and improving outcomes.
Area of Science:
- Neurology
- Metabolic Disorders
- Genetics
Background:
- Seizures are a key clinical sign of inborn errors of metabolism (IEM).
- Myoclonic seizures and very early onset seizures suggest a potential metabolic disorder.
- Rapid advancements in neurogenetics and metabolism necessitate updated diagnostic and therapeutic approaches.
Purpose of the Study:
- To highlight the link between seizure characteristics and IEM.
- To emphasize the importance of recognizing metabolic etiologies in epilepsy.
- To provide updated guidance on diagnostic and therapeutic strategies for IEM-related epilepsies.
Main Methods:
- Review of clinical manifestations, including seizure types and onset age.
- Correlation analysis of electroencephalogram (EEG) patterns with specific IEMs.
- Discussion of current laboratory and imaging diagnostic tools.
- Outline of therapeutic considerations for IEM-associated seizures.
Main Results:
- Specific seizure patterns and onset ages are associated with particular IEMs.
- Early identification of metabolic disorders is critical for timely intervention.
- Integrated diagnostic and treatment protocols can improve patient management.
Conclusions:
- Inborn errors of metabolism should be strongly considered in infants presenting with myoclonic or early-onset seizures.
- A comprehensive approach combining neurogenetic and metabolic investigations is essential.
- Prompt diagnosis and targeted therapies can significantly alter the course of IEM-related epilepsy.